MedTrace Logo

Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1

NCT00078143 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-01-12

No results posted yet for this study

Summary

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Conditions

  • Substance-Related Disorders

Interventions

BEHAVIORAL

Behavior Therapy

Sponsors & Collaborators

  • University of Cincinnati

    lead OTHER

Principal Investigators

  • Theresa Winhusen, Ph.D. · University of Cincinnati

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00078143 on ClinicalTrials.gov